10.01.24 -- Dear Data Analysts, AI Is Not Replacing You

Explore the rising prevalence of NASH/MASH, its debilitating effects, and the urgent need for patient-centric approaches in clinical research.

One of the biggest risks for medical products and companies is the failure to report adverse events. But what leads to underreporting? Here are five core reasons behind most adverse event underreporting.

In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.

Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.

Simplify your consent process with SmartSignals eConsent—enhance participant understanding, streamline management, reduce errors, and ensure compliance with flexible, multilingual solutions.

Discover a flexible, cost-effective platform tailored to Phase I studies, providing rapid, efficient study builds, seamless transitions, and scalable solutions for early-stage clinical research.

Complex studies often require costly customizations and lengthy timelines. Learn how our innovative study designer can streamline study launch, save you time, and reduce costs.